Morgan Stanley’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9K | Sell |
|
|||||
|
2025
Q1 | $30.7K | Sell |
|
|||||
|
2024
Q4 | $253K | Buy |
|
|||||
|
2024
Q3 | $264K | Buy |
|
|||||
|
2024
Q2 | $619K | Sell |
|
|||||
|
2024
Q1 | $795K | Sell |
|
|||||
|
2023
Q4 | $1.63M | Buy |
|
|||||
|
2023
Q3 | $462K | Buy |
|
|||||
|
2023
Q2 | $275K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q4 | $36.5K | Sell |
|
|||||
|
2022
Q3 | $123K | Sell |
|
|||||
|
2022
Q2 | $181K | Sell |
|
|||||
|
2022
Q1 | $6.34M | Sell |
|
|||||
|
2021
Q4 | $8.35M | Buy |
|
|||||
|
2021
Q3 | $556K | Sell |
|
|||||
|
2021
Q2 | $1.38M | Buy |
|
|||||
|
2021
Q1 | $70K | Sell |
|
|||||
|
2020
Q4 | $157K | Buy |
|
|||||
|
2020
Q3 | $43K | Sell |
|
|||||
|
2020
Q2 | $93K | Buy |
|
|||||
|
2020
Q1 | $61K | Sell |
|
|||||
|
2019
Q4 | $347K | Buy |
|
|||||
|
2019
Q3 | $58K | Buy |
|
|||||
|
2019
Q2 | $7K | Sell |
|
|||||
|
2019
Q1 | $25K | Sell |
|
|||||
|
2018
Q4 | $132K | Buy |
|
|||||
|
2018
Q3 | $182K | Buy |
|
|||||
|
2018
Q2 | $47K | Buy |
|